Insights
We’re acknowledged for our strong market insight and technical know-how
Insights
EMA seeks feedback on draft guidance for when biologics qualify as new active substances
14 April 2023
Insights
The Moderna v Pfizer-Biontech COVID-19 vaccine dispute: a brief explanation
30 November 2022
Insights
Patents to biological medicines in combination: is two really better than one?
23 September 2022